• head_banner_01

2022 New Style Powder Anticancer Afatinib - Atosiban Acetate Used for Anti Premature Birth – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our goods are broadly recognized and reliable by users and can meet consistently switching financial and social demands of Sulconazole Nitrate, Sodium And Chloride, Benzaldehyde 2-Bromo-5-Chloro-, We can easily offer you by far the most aggressive prices and good quality, because we've been much additional Specialist! So please will not hesitate to call us.
2022 New Style Powder Anticancer Afatinib - Atosiban Acetate Used for Anti Premature Birth – Gentolex Detail:

Product Detail

Name  Atosiban
CAS number  90779-69-4
Molecular formula  C43H67N11O12S2
Molecular weight  994.19
EINECS Number  806-815-5
Boiling point  1469.0±65.0 °C (Predicted)
Density  1.254±0.06 g/cm3(Predicted)
Storage conditions  -20°C
Solubility  H2O:≤100 mg/mL

Description

Atosiban acetate is a disulfide-bonded cyclic polypeptide consisting of 9 amino acids. It is a modified oxytocin molecule at positions 1, 2, 4 and 8. The N-terminus of the peptide is 3-mercaptopropionic acid (thiol and The sulfhydryl group of [Cys]6 forms a disulfide bond), the C-terminal is in the form of an amide, the second amino acid at the N-terminal is an ethylated modified [D-Tyr(Et)]2, and atosiban acetate is used in medicines as vinegar It exists in the form of an acid salt, commonly known as atosiban acetate.

Application

Atosiban is an oxytocin and vasopressin V1A combined receptor antagonist, the oxytocin receptor is structurally similar to the vasopressin V1A receptor. When the oxytocin receptor is blocked, oxytocin can still act through the V1A receptor, so it is necessary to block the above two receptor pathways at the same time, and a single antagonism of one receptor can effectively inhibit uterine contraction. This is also one of the main reasons why β-receptor agonists, calcium channel blockers and prostaglandin synthase inhibitors cannot effectively inhibit uterine contractions.

Effect

Atosiban is a combined receptor antagonist of oxytocin and vasopressin V1A, its chemical structure is similar to the two, and it has a high affinity for receptors, and competes with oxytocin and vasopressin V1A receptors, thereby blocking the action pathway of oxytocin and vasopressin and reducing uterine contractions.


Product detail pictures:

2022 New Style Powder Anticancer Afatinib - Atosiban Acetate Used for Anti Premature Birth – Gentolex detail pictures

2022 New Style Powder Anticancer Afatinib - Atosiban Acetate Used for Anti Premature Birth – Gentolex detail pictures


Related Product Guide:

With a positive and progressive attitude to customer's interest, our enterprise continually improves our products excellent to meet the wants of customers and further focuses on safety, reliability, environmental requirements, and innovation of 2022 New Style Powder Anticancer Afatinib - Atosiban Acetate Used for Anti Premature Birth – Gentolex , The product will supply to all over the world, such as: Iran, India, The Swiss, Insisting on the high quality generation line management and customers expert assistance, we now have designed our resolution to supply our buyers using the to start with amount getting and just after services practical experience. Maintaining the prevailing friendly relations with our buyers, we however innovate our solution lists all of the time to satisfy the brand new demands and adhere to the most up-to-date development of the market in Malta. We have been ready to face the worries and make the improve to understand all the possibilities in international trade.
  • This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
    5 Stars By Esther from Algeria - 2018.09.08 17:09
    The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
    5 Stars By Jean from Ireland - 2018.11.06 10:04
    Write your message here and send it to us